Last reviewed · How we verify
PAD induction
At a glance
| Generic name | PAD induction |
|---|---|
| Sponsor | Janssen-Cilag Pty Ltd |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Anatomical Evaluation of Supraspinatus Through Ultrasonography and Biomechanical Measurements Following Different Combinations of Physical Therapies in Patients of Supraspinatus Tendinitis (NA)
- The Use of Acupuncture to Reduce Chemotherapy Induced Peripheral Neuropathy in Gynaecological Cancer Patients (NA)
- Novel Point-of-care Sweat Chloride Testing Device for Monitoring CFTR Function (NA)
- Effects of Diagonal Proprioceptive Neuromuscular Facilitation Patterns on Pain and Functional Outcomes in Patients With Knee Osteoarthritis (NA)
- Targeted Hypothermia Versus Targeted Normothermia After Convulsive Refractory Status Epilepticus (PHASE3)
- Non-invasive MSOT Examination of Muscle Oxygenation in Athletes and PAD Patients
- Effect of Transcutaneous Electrical Nerve Stimulation Based on Wrist-ankle Acupuncture Theory on Postoperative Pain After Video-assisted Thoracoscopic Surgery (NA)
- Effect of Transcutaneous Electrical Nerve Stimulation Based on Wrist-ankle Acupuncture Theory on EC50 of Remifentanil Inhibiting Responses to Tracheal Intubation Under General Anesthesia (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- PAD induction CI brief — competitive landscape report
- PAD induction updates RSS · CI watch RSS
- Janssen-Cilag Pty Ltd portfolio CI